Literature DB >> 10595691

Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology.

B Symonides1, J Chodakowska, A Januszewicz, M Lapinski, M Januszewicz, O Rowiński, J Szmidt, A Kuch-Wocial, M Kurzyna, G Małek, H Berent, C Szmigielski, W Januszewicz.   

Abstract

The aim of this study was to evaluate the effect of renal artery stenosis (RAS) correction in hypertensive patients on 24 h SBP, 24 h DBP, creatinine clearance (GFR), urinary albumin excretion (UAE) and LV morphology and mass (LVMI). A total of 61 hypertensive patients with RAS undergoing PTRA and/or surgical treatment entered the prospective study. The final analysis was done in 44 patients (age range 45.8 +/- 16.2 years) with RAS (atherosclerosis (ASC) 31 patients, fibromuscular dysplasia (FMD) 12 patients, arteritis 1 patient) who underwent PTRA (34 patients) or surgical treatment (10 patients) and presented no Doppler signs of restenosis (or a new stenosis) during 1-year observation. The pre-interventional assessment repeated after 6 and 12 months included ABPM, GFR, UAE and echocardiography. The results were analysed in the combined group (CG) and in according aetiology. 24 h SBP and 24 h DBP decreased in all groups 6 months post-intervention and did not change further. Cure of HT was observed in 35% and 29% of ASC patients at 6 and 12 months respectively; and in 58% of FMD patients. Failure rate at 12 months was 48% in ASC against 25% in FMD. The mean GFR in CG was higher 12 months after intervention. The increase in GFR was noted in 45% of patients, the decrease in 25% of patients at 12 months. Normal values of UAE were found in 71% of patients, pre- and post-intervention alike. Mean LVMI and number of patients with LVH in CG decreased already during the initial 6 months post-intervention and did not change further. In conclusion, correction of RAS leads to cure of or improved control of hypertension in the majority of the patients with FMD, but in the ASC group in about half of cases no BP cure or improvement was seen. The renal function was improved or stable in two-thirds of patients after revascularization. Successful renal revascularization was followed by regression of LVH, which was evident within 6 months post-intervention.

Entities:  

Mesh:

Year:  1999        PMID: 10595691     DOI: 10.1080/080370599439661

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  5 in total

1.  Cardiovascular disease: Stenting in renovascular disease--good news for the heart?

Authors:  Lars Christian Rump; Lorenz Sellin
Journal:  Nat Rev Nephrol       Date:  2012-05-29       Impact factor: 28.314

2.  High renin hypertension in focal renal fibromuscular dysplasia: turn off of renin system angiotensin overactivation by renal angioplasty cured high blood pressure and quickly reversed myocardial hypertrophy.

Authors:  Simona Merla; Riccardo Simoni; Stefano Tedeschi; Massimiliano Ferrari; Giovanni Passeri; Carla Marcato; Enrico Epifani; Ignazio Semproni; Giulia Zini; Ignazio Verzicco; Pietro Coghi; Riccardo Volpi; Aderville Cabassi
Journal:  Acta Biomed       Date:  2021-04-30

3.  A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) - one-year results of a pre-maturely terminated study.

Authors:  Thomas Zeller; Hans Krankenberg; Andrejs Erglis; Erwin Blessing; Torsten Fuss; Dierk Scheinert; Ralf Weser; Beatrix B Doerr; Wilfrid D Yollo; Joerg Radermacher
Journal:  Trials       Date:  2017-08-14       Impact factor: 2.279

4.  Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study.

Authors:  Darren Green; Diana Vassallo; Kelly Handley; Natalie Ives; Keith Wheatley; Constantina Chrysochou; Janet Hegarty; Julian Wright; Jon Moss; Rajan K Patel; Chris Deighan; John Webster; Peter Rowe; Sue Carr; Jenny Cross; Jamie O'Driscoll; Raj Sharma; Patrick Mark; Philip A Kalra
Journal:  BMC Nephrol       Date:  2019-06-14       Impact factor: 2.388

Review 5.  Renal artery stenosis and cardiovascular risk.

Authors:  Shahzad Shafique; Aldo J Peixoto
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-03       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.